{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:09:37Z","timestamp":1784761777428,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jfo.2016.11.013","type":"journal-article","created":{"date-parts":[[2017,3,17]],"date-time":"2017-03-17T07:01:20Z","timestamp":1489734080000},"page":"177-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Traitement des \u0153d\u00e8mes maculaires\u00a0: comparaison de l\u2019efficacit\u00e9 et de la tol\u00e9rance des injections sous-conjonctivales de triamcinolone, des injections sous-t\u00e9noniennes de triamcinolone et des injections intra-vitr\u00e9ennes de l\u2019implant de dexam\u00e9thasone"],"prefix":"10.1016","volume":"40","author":[{"given":"C.","family":"Carbonni\u00e8re","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Couret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bl\u00e9riot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Lebreton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Mass\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Le Meur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Lebranchu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2016.11.013_bib0180","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0161-6420(85)34001-0","article-title":"Standardization of vitreal inflammatory activity in intermediate and posterior uveitis","volume":"92","author":"Nussenblatt","year":"1985","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2016.11.013_bib0185","first-page":"695","article-title":"Periocular injection of steroids","volume":"76","author":"Nozik","year":"1972","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"10.1016\/j.jfo.2016.11.013_bib0190","first-page":"71","article-title":"Posterior sub-Tenon injections of repository corticosteroids in uveitis patients with cystoid macular edema","volume":"39","author":"Yoshikawa","year":"1995","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.jfo.2016.11.013_bib0195","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.ophtha.2014.05.021","article-title":"Periocular corticosteroid injections in uveitis: effects and complications","volume":"121","author":"Sen","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2016.11.013_bib0200","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jfo.2014.04.010","article-title":"[Safety and efficacy of subconjunctival triamcinolone injections in the management of uveitic macular edema: retrospective study of thirty-one cases]","volume":"37","author":"Bleriot","year":"2014","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2016.11.013_bib0205","first-page":"385","article-title":"Posterior sub-Tenon's injections of corticosteroids in uveitis patients with cystoid macular edema","volume":"32","author":"Jennings","year":"1988","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.jfo.2016.11.013_bib0210","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.ophtha.2014.04.012","article-title":"Dexamethasone intravitreal implant in the treatment of persistent uveitic macular edema in the absence of active inflammation","volume":"121","author":"Cao","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2016.11.013_bib0215","unstructured":"Yee D, Edwards P, Ahmed S, Kahook K, Prinzi R. Comparison of complications and efficacy of dexamethasone intravitreal implant versus intravitreal triamcinolone for macular edema."},{"key":"10.1016\/j.jfo.2016.11.013_bib0220","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1167\/iovs.10-5285","article-title":"Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant","volume":"52","author":"Chang-Lin","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2016.11.013_bib0225","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1136\/bjophthalmol-2014-306159","article-title":"Effectiveness and safety of dexamethasone implants for post-surgical macular oedema including Irvine-Gass syndrome: the EPISODIC study","volume":"99","author":"Bellocq","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2016.11.013_bib0230","series-title":"HAS, Commission de la transparence, Ozurdex 700\u00a0microgrammes, implant intravitr\u00e9en avec applicateur, 2011","author":"Allergan","year":"2011"},{"key":"10.1016\/j.jfo.2016.11.013_bib0235","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0002-9394(98)00003-8","article-title":"Dexamethasone concentration in vitreous and serum after oral administration","volume":"125","author":"Weijtens","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2016.11.013_bib0240","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0002-9394(99)00129-4","article-title":"High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection","volume":"128","author":"Weijtens","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2016.11.013_bib0245","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1007\/s00417-005-0133-1","article-title":"Intravitreal dexamethasone as adjuvant in the treatment of postoperative endophthalmitis: a prospective randomized trial","volume":"243","author":"Gan","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2016.11.013_bib0250","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/S0161-6420(99)90342-1","article-title":"Visual acuity impairment in patients with retinitis pigmentosa at age 45\u00a0years or older","volume":"106","author":"Grover","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2016.11.013_bib0255","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1167\/iovs.05-0981","article-title":"Visual acuities \u2018hand motion\u2019 and \u2018counting fingers\u2019 can be quantified with the freiburg visual acuity test","volume":"47","author":"Schulze-Bonsel","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2016.11.013_bib0260","doi-asserted-by":"crossref","first-page":"8939","DOI":"10.1167\/iovs.11-8193","article-title":"Logarithmic transformation of spectral-domain optical coherence tomography data in uveitis-associated macular edema","volume":"52","author":"Payne","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2016.11.013_bib0265","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.ophtha.2009.12.014","article-title":"A proposed method of logarithmic transformation of optical coherence tomography data for use in clinical research","volume":"117","author":"Ferris","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2016.11.013_bib0270","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ajo.2009.03.034","article-title":"Retinal thickening in iridocyclitis","volume":"148","author":"Castellano","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2016.11.013_bib0275","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archophthalmol.2010.339","article-title":"Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis","volume":"129","author":"Lowder","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2016.11.013_bib0280","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00347-012-2737-2","article-title":"[Reliability and safety of intravitreal Ozurdex injections. The ZERO study]","volume":"111","author":"Schmitz","year":"2014","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.jfo.2016.11.013_bib0285","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1167\/iovs.12-11463","article-title":"Dexamethasone intravitreal implant for treatment of patients with recalcitrant macular edema resulting from Irvine-Gass syndrome","volume":"54","author":"Dutra Medeiros","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2016.11.013_bib0290","first-page":"1423","article-title":"Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant","volume":"4","author":"Myung","year":"2010","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jfo.2016.11.013_bib0295","first-page":"396","article-title":"[Dexamethason implant in the treatment of macular edema in retinal vein occlusion and intraocular inflammatory disease]","volume":"230","author":"Brunner","year":"2013","journal-title":"Klin Monatsbl\u00e4tter F\u00fcr Augenheilkd Fortbild"},{"key":"10.1016\/j.jfo.2016.11.013_bib0300","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/IAE.0b013e31829f7495","article-title":"Impact of intravitreal dexamethasone implant (Ozurdex) on macular morphology and function","volume":"34","author":"Querques","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2016.11.013_bib0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12348-011-0042-x","article-title":"Wandering Ozurdex(\u00ae) implant","volume":"2","author":"Bansal","year":"2012","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.jfo.2016.11.013_bib0310","first-page":"139","article-title":"Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema","volume":"5","author":"Herrero-Vanrell","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jfo.2016.11.013_bib0315","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0002-9394(21)00232-4","article-title":"Echographic localization of corticosteroids after periocular injection","volume":"103","author":"Freeman","year":"1987","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2016.11.013_bib0320","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0886-3350(99)00449-6","article-title":"Avoiding conjunctival necrosis after periocular depot corticosteroid injection","volume":"26","author":"Fogla","year":"2000","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.jfo.2016.11.013_bib0325","first-page":"1048","article-title":"[Intraocular pressure elevation after subtenon injection of triamcinolone acetonide during uveitis]","volume":"25","author":"Bui Quoc","year":"2002","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2016.11.013_bib0330","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0002-9394(14)73759-6","article-title":"The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis","volume":"120","author":"Helm","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2016.11.013_bib0335","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.ajo.2006.05.023","article-title":"Intravitreal triamcinolone acetonide concentration after subtenon injection","volume":"142","author":"Thomas","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2016.11.013_bib0340","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.ophtha.2010.03.033","article-title":"Intraocular and systemic pharmacokinetics of triamcinolone acetonide after a single 40-mg posterior subtenon application","volume":"117","author":"Shen","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2016.11.013_bib0345","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1089\/jop.2012.0208","article-title":"Subconjunctival triamcinolone acetonide in the management of ocular inflammatory disease","volume":"29","author":"Athanasiadis","year":"2013","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jfo.2016.11.013_bib0175","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/jop.1993.9.35","article-title":"Identification of high intraocular pressure responders to topical ophthalmic corticosteroids","volume":"9","author":"Bartlett","year":"1993","journal-title":"J Ocul Pharmacol"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551217300773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551217300773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:06:47Z","timestamp":1759259207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551217300773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0181551217300773"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2016.11.013","relation":{},"ISSN":["0181-5512"],"issn-type":[{"value":"0181-5512","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Traitement des \u0153d\u00e8mes maculaires\u00a0: comparaison de l\u2019efficacit\u00e9 et de la tol\u00e9rance des injections sous-conjonctivales de triamcinolone, des injections sous-t\u00e9noniennes de triamcinolone et des injections intra-vitr\u00e9ennes de l\u2019implant de dexam\u00e9thasone","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2016.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}